Why CRISPR Therapeutics Stock Fell 25.2% in July
What happened
Shares of CRISPR Therapeutics(NASDAQ:CRSP) lost 25.2% of their value in July, according to data from S&P Global Intelligence. The stock was at $161.22 when the market opened on July 1, and fell to $121.02 by the time it closed on Friday, July…
